Nachrichten zu Genmab

Startseite > Aktien > Genmab > Nachrichten

Aktie

ISIN: DK0010272202 WKN: 565131 SYM: GE9 Land Flagge DK

Dänemark

Zur Watchlist hinzufügen Zum Portfolio hinzufügen

Zum Portfolio hinzufügen

212,10

EUR

-0,24 %

-0,50 EUR

Letzter Kurs 20:19:14 Tradegate

Geldkurs

20:38:10

211,30

EUR

25 STK

Briefkurs

20:38:10

213,20

EUR

25 STK

Genmab Aktie kaufen

Major Shareholder Announcement 19:55 Uhr · globenewswire · Genmab
Grant of Restricted Stock Units and Warrants to Employees in Genmab 26.09.24 · globenewswire · Genmab
Investigational Rinatabart Sesutecan (Rina-S) Shows Promising Anti-Tumor Activity as Single Agent in Heavily Pretreated Patients with Ovarian and Endometrial Cancers in Phase 1/2 Clinical Trial 15.09.24 · globenewswire · Genmab
Capital Increase in Genmab as a Result of Employee Warrant Exercise 10.09.24 · globenewswire · Genmab
Genmab A/S (Analyse): Kommt jetzt der Durchbruch? 06.09.24 · Aktienbewertung.de · GenmabAnzeige
Genmab to Present at Morgan Stanley 22nd Annual Global Healthcare Conference 26.08.24 · globenewswire · Genmab
TEPKINLY (epcoritamab) Receives Second European Commission Approval for the Treatment of Adults with Relapsed/Refractory Follicular Lymphoma 19.08.24 · globenewswire · Genmab
Genmab Announces Changes to its Executive Committee 16.08.24 · globenewswire · Genmab
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons 13.08.24 · globenewswire · Genmab
Capital Increase in Genmab as a Result of Employee Warrant Exercise 13.08.24 · globenewswire · Genmab
Genmab Announces Financial Results for the First Half of 2024 08.08.24 · globenewswire · Genmab
Genmab Updates 2024 Financial Guidance 08.08.24 · globenewswire · Genmab

Major Shareholder Announcement 48 Leser

Major Shareholder Announcement 48 Leser

Capital Increase in Genmab as a Result of Employee Warrant Exercise 368 Leser
Investigational Rinatabart Sesutecan (Rina-S) Shows Promising Anti-Tumor Activity as Single Agent ... 260 Leser
Genmab A/S (Analyse): Kommt jetzt der Durchbruch? 188 Leser
Grant of Restricted Stock Units and Warrants to Employees in Genmab 132 Leser
Major Shareholder Announcement 48 Leser

wO Börsenlounge: Samsung SDI \| Merck \| Bayer - Pille von Novo Nordisk ist besser als die Spritze! 10940 Leser
Genmab Takes Full Control of Acasunlimab Development Program 596 Leser
Transactions in Connection with Share Buy-back Program 452 Leser
Genmab Updates 2024 Financial Guidance 444 Leser
Genmab Announces Changes to its Executive Committee 376 Leser
Capital Increase in Genmab as a Result of Employee Warrant Exercise 368 Leser
Genmab to Present New and Updated Results From Multiple Clinical Trials Evaluating Epcoritamab ... 368 Leser
TIVDAK (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic ... 348 Leser
Genmab Completes Acquisition of ProfoundBio 348 Leser
Genmab Announces Financial Results for the First Quarter of 2024 340 Leser